The Trump administration previously cut off funding to global HIV/AIDS programs, including in Zambia, in an effort to reduce ...

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for the latest sci-tech news updates. It's now a manageable infection. A ...

Merck has FDA approval for a new combination drug for HIV, giving patients a new treatment option and an alternative to a blockbuster Gilead Sciences pill that comes with tolerability and side effect ...

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...

Gilead Sciences posted better-than-anticipated earnings for the first quarter. Shares fell anyway.

After abruptly pausing PEPFAR on Tuesday — the U.S.-led HIV/AIDS program created in 2003 and credited with saving 25 million lives globally — the Trump administration issued an ambiguous waiver for ...

HOUSTON — With President Trump's "Big, Beautiful Bil l," making major cuts to Medicaid, health care professionals and patients are warning of the potentially deadly consequences for people living with ...

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...

Fewer patients are visiting some HIV treatment centres in Senegal amid a wave of arrests targeting 2SLGBTQ+ people, according ...